Drug-Induced Lung Injury

Focused on Drug-Induced Lung Injury (DLI), providing a comprehensive overview of the condition. It explains why DLI is currently a significant medical issue, noting the increasing number of reported cases due to new drug classes like molecular-targeted agents and immune checkpoint inhibitors, and highlights ethnic differences in incidence, particularly among the Japanese population. The text details the clinical features and diagnostic challenges of DLI, emphasizing the importance of excluding other causes and using imaging techniques like HRCT, while also discussing the utility and limitations of blood biomarkers like KL-6, SP-A, and SP-D, and the Drug Lymphocyte Stimulation Test (DLST). Furthermore, the material categorizes DLI by causative drug classes (e.g., antineoplastic, antirheumatic, antiarrhythmic, and herbal medicines), describes their varying clinical patterns (such as Diffuse Alveolar Damage or Organizing Pneumonia), and outlines therapeutic strategies, which often involve drug cessation and corticosteroid administration.Get the Book now from Amazon:https://www.amazon.com/Drug-Induced-Lung-Injury-Respiratory-Disease-ebook/dp/B076J5S8ZX?&linkCode=ll1&tag=cvthunderx-20&linkId=ea367a15a6cc323d5a2140628b6fe98a&language=en_US&ref_=as_li_ss_tlYou can listen and download our episodes for free on more than 10 different platforms:https://linktr.ee/pharmacy_simpleProduced by:https://www.podcaistudio.com/